Looking for selectivity among cytochrome P450s inhibitors

被引：23

作者：

Cavalli, A ^{[1
]}

Recanatini, M ^{[1
]}

机构：

[1] Univ Bologna, Dept Pharmaceut Sci, I-40126 Bologna, Italy

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2002年 / 45卷 / 02期

关键词：

D O I：

10.1021/jm015567k

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Cytochrome P450s 19 and 17 are very important pharmacological targets in two different fields of cancer chemotherapy. We present here a theoretical study aimed at explaining the molecular basis of inhibitor affinity and selectivity for either P450 19 or P450 17. Docking simulations of two compounds pointed out the major physicochemical features associated with inhibitory activity. Our results, in agreement with site-directed mutagenesis experiments, could be of relevant utility when designing new P450 19 and P450 17 inhibitors.

引用

页码：251 / 254

页数：4

共 17 条

[11] Evaluation of the mechanism of aromatase cytochrome P450 - A site-directed mutagenesis study [J].

Kao, YC ;

Korzekwa, KR ;

Laughton, CA ;

Chen, S .

EUROPEAN JOURNAL OF BIOCHEMISTRY, 2001, 268 (02) :243-251

[12] A MOLECULAR-MODEL FOR THE INTERACTION BETWEEN VOROZOLE AND OTHER NONSTEROIDAL INHIBITORS AND HUMAN CYTOCHROME-P450 19 (P450 AROMATASE) [J].

KOYMANS, LMH ;

MOEREELS, H ;

VANDENBOSSCHE, H .

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1995, 53 (1-6) :191-197

[13] THE SEQUENCE HOMOLOGIES OF CYTOCHROMES-P-450 AND ACTIVE-SITE GEOMETRIES [J].

LEWIS, DFV ;

MOEREELS, H .

JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1992, 6 (03) :235-252

[14] IMPROVED TOOLS FOR BIOLOGICAL SEQUENCE COMPARISON [J].

PEARSON, WR ;

LIPMAN, DJ .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (08) :2444-2448

[15] A new class of nonsteroidal aromatase inhibitors:: Design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17α-hydroxylase/C17,20-lyase [J].

Recanatini, M ;

Bisi, A ;

Cavalli, A ;

Belluti, F ;

Gobbi, S ;

Rampa, A ;

Valenti, P ;

Palzer, M ;

Palusczak, A ;

Hartmann, RW .

JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (05) :672-680

[16] IS THERE A CASE FOR P-450 INHIBITORS IN CANCER-TREATMENT [J].

VANWAUWE, JP ;

JANSSEN, PAJ .

JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (10) :2231-2239

[17] MOLECULAR-BASIS OF APPARENT ISOLATED 17,20-LYASE DEFICIENCY - COMPOUND HETEROZYGOUS MUTATIONS IN THE C-TERMINAL REGION (ARG(496)-]CYS, GLN(461)-]STOP) ACTUALLY CAUSE COMBINED 17-ALPHA-HYDROXYLASE 17,20-LYASE DEFICIENCY [J].

YANASE, T ;

WATERMAN, MR ;

ZACHMANN, M ;

WINTER, JSD ;

SIMPSON, ER ;

KAGIMOTO, M .

BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1139 (04) :275-279

← 1 2 →